Close
| |

Home Page

Company Database

Licensing Deals

Investors

Latest updates

26 April 2015
Updates within the latest 30 days:

News in the Life Sciences Industry

Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 - Next
Reset 

Stempeutics Gets Stem Cell Patent in China (Chinese Application Number: CN201080053627) for its Novel Stem Cell Drug 'Stempeucel'

BANGALORE, India, April 27, 2015 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 27 Apr 2015
Related companies:  Stempeutics Research Malaysia Sdn Bhd.

Stempeutics Gets Stem Cell Patent in China (Chinese Application number: CN201080053627) for its Novel Stem Cell Drug 'Stempeucel®'

BANGALORE, April 27, 2015 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 27 Apr 2015
Related companies:  Stempeutics Research Malaysia Sdn Bhd.

Novogen Posts Details on Rights Issue Offering for Shareholders

SYDNEY, April 27, 2015 /PRNewswire/ -- US-Australian drug discovery company, Novogen Limited (NRT: ASX; NVGN: NASDAQ) (Company), announced last week that it lodged a prospectus with ASIC on23 April 2015 relating to its pro rata non-renounceable rights issue (Offering). The prospectus has been... Read more ››

By: PR Newswire Association LLC. - 27 Apr 2015

Cancer Experts Detail How 'Big Data' Plays a Critical Role in Improving Clinical Decision-Making in Oncology Treatments at 3rd ESTRO Forum

BARCELONA, April 26, 2015 /PRNewswire/ -- Cancer experts have reported how a Varian Medical Systems (NYSE: VAR) supported project in the area of distributed learning is helping to harness the power of "big data" for the benefit of patients. Speakers at a Varian-hosted symposium at the 3(rd) ESTRO... Read more ››

By: PR Newswire Association LLC. - 26 Apr 2015

Ikonopedia Selected to Provide Breast Imaging Report Generation Capabilities for BelleBridge's Breast Telemedicine Services

ORLANDO, April 26, 2015 /PRNewswire/ -- Ikonopedia announced today that its breast imaging reporting tools and MQSA management system have been selected for use by BelleBridge, which provides telemedicine services for interpretations of breast screening and diagnostic examinations. Ikonopedia... Read more ››

By: PR Newswire Association LLC. - 26 Apr 2015

Mediclinic Middle East Announces Construction of New Hospital in Dubai

DUBAI, April 26, 2015 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 26 Apr 2015

Nepal Earthquake: Direct Relief Offers $100 Million in Medical Inventory, Commits Initial $50 Thousand Cash to Emergency Response

SANTA BARBARA, Calif., April 26, 2015 /PRNewswire-USNewswire/ -- As the massive damage, tragic loss of life, and widespread injuries from today's magnitude 7.8 earthquake in Nepal comes into focus, Direct Relief has made an initial cash commitment of $50,000 for the immediate deployment of emergency... Read more ››

By: PR Newswire Association LLC. - 26 Apr 2015

International Medical Corps Responding to Devastating Earthquake in Nepal

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2015

Late-Breaking Oral Presentation at The International Liver Congress™ (ILC 2015) Highlights RG-101's Potent, Durable and Pan-Genotypic Effects in Diverse HCV Population

LA JOLLA, Calif., April 25, 2015 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today presented new data strengthening the profile of RG-101, a wholly-owned, GalNAc-conjugated... Read more ››

By: PR Newswire Association LLC. - 25 Apr 2015
Related companies:  Regulus Therapeutics Inc.

AbbVie Presents Late-Breaking, Preliminary Phase 3b Data with VIEKIRAX® + EXVIERA® in Chronic Hepatitis C Patients with Renal Impairment at The International Liver Congress™ 2015

VIENNA, April 25, 2015 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced new, preliminary safety and efficacy data from the first cohort of its ongoing, Phase 3b RUBY-I study. RUBY-I is evaluating VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA® (dasabuvir tablets) with or... Read more ››

By: PR Newswire Association LLC. - 25 Apr 2015
Related companies:  Enanta Pharmaceuticals, Inc. | AbbVie Inc.

New Leksell Gamma Knife to benefit more patients with brain disease

BARCELONA, Spain, April 25, 2015 /PRNewswire/ -- With the introduction of Elekta's new Leksell Gamma Knife® Icon(TM), the benefits of precision cranial radiosurgery are now available for more patients with a wider variety of tumor types and sizes. This latest generation stereotactic radiosurgery... Read more ››

By: PR Newswire Association LLC. - 25 Apr 2015
Related companies:  Elekta AB

Apollo Medical Holdings Announces reverse stock split and nasdaq listing submission

GLENDALE, Calif., April 24, 2015 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed") (OTC-QB: AMEH), an integrated patient-centered, physician-driven healthcare delivery company, today announced that it has... Read more ››

By: PR Newswire Association LLC. - 25 Apr 2015

Pharmaceutical Industry Using New Technologies to Adjust Their Marketing and Research Approaches for Consumers

CHAPEL HILL, N.C., April 24, 2015 /PRNewswire/ -- New technologies and online platforms have dramatically increased the ability of consumers to educate themselves about products and companies. Likewise, these same technologies have expanded the tools and techniques available to market researchers... Read more ››

By: PR Newswire Association LLC. - 25 Apr 2015

Work Around the Clock: Building Effective Global Capabilities

CHAPEL HILL, N.C., April 24, 2015 /PRNewswire/ -- In today's ever-changing and increasingly global marketplace, organizations are establishing employee groups around the world to access diverse skill sets, set low-cost workforce and round-the-clock business hours. While there are many areas to... Read more ››

By: PR Newswire Association LLC. - 25 Apr 2015

Attention: We live in the future. Order contact lenses from your wrist with the 1-800 CONTACTS app for Apple Watch

DRAPER, Utah, April 24, 2015 /PRNewswire/ -- Today, humanity takes a massive step toward reaching our shared dreams of jetpacks, hoverboards, the singularity, and fat-free cronuts: 1-800 CONTACTS announces their new Apple Watch app which allows the reordering of contact lenses in just two taps.

... Read more ››
By: PR Newswire Association LLC. - 24 Apr 2015

Researchers find alarming rise in cost of MS drugs over past two decades

PORTLAND, Ore., April 24, 2015 /PRNewswire/ -- A new study shows an "alarming rise" over the last 20 years in the costs of drugs used to slow the progression of multiple sclerosis or reduce the frequency of attacks, according to a study led by researchers at Oregon Health & Science University... Read more ››

By: PR Newswire Association LLC. - 24 Apr 2015
Related companies:  Oregon Translational Research and Development Institute | Oregon Bioscience Association | Oregon Health and Sciences University (OHSU)

Lilly's CYRAMZA® (ramucirumab) Receives Fourth FDA Approval

INDIANAPOLIS, April 24, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has received its fourth U.S. Food and Drug Administration (FDA) approval for CYRAMZA(®) (ramucirumab). CYRAMZA (ramucirumab injection 10 mg/mL solution) is now also indicated in combination with FOLFIRI (irinotecan,... Read more ››

By: PR Newswire Association LLC. - 24 Apr 2015

MEND™ Regenerative Nutrition for Injury/Surgery Signed to Medical Distribution Agreement with MDgenesis LLC

NEW YORK, April 24, 2015 /PRNewswire-iReach/ -- Nutrition For Healing® LLC today announces that MEND(TM), an all-natural nutrient rich regenerative dietary supplement formulated to support enhance healing from musculoskeletal injuries and surgeries, will begin distribution with MDgenesis LLC,... Read more ››

By: PR Newswire Association LLC. - 24 Apr 2015

IGI Laboratories To Hold Conference Call For 1st Quarter 2015 Results

BUENA, N.J., April 24, 2015 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:15 pm ET on Tuesday, April 28, 2015 to discuss the 1st quarter 2015 results.

Read more ››
By: PR Newswire Association LLC. - 24 Apr 2015
Related companies:  IGI Laboratories, Inc.

Perrigo Rejects Mylan Unsolicited Offer

DUBLIN, April 24, 2015 /PRNewswire/ -- Perrigo Company plc ("Perrigo" or the "Company") (NYSE: PRGO, TASE) today announced its rejection of the unsolicited offer from Mylan NV ("Mylan") (NASDAQ: MYL) to acquire all of the outstanding shares of Perrigo for $60.00 per share in cash and 2.2 Mylan... Read more ››

By: PR Newswire Association LLC. - 24 Apr 2015
Related companies:  Perrigo Company | Mylan Dura Gmbh
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 - Next